Chinese citizens can receive COVID-19 vaccines as early as November  Daily MailView Full coverage on Google News
The country has four Covid-19 vaccines in the final stage of clinical trials.The country has four Covid-19 vaccines in the final stage of clinical trials.

China coronavirus vaccine may be ready for public in November: official - World - DAWN.COM

The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.

U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate | Reuters

Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.

After AstraZeneca, some quit J&J COVID-19 trial in Spain | News | Al Jazeera

Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.

Top Oxford professor behind Covid-19 vaccine reiterates safety is 'top of the list' | Daily Mail Online

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Americans will need to take pandemic precautions well into 2021 — yes, even after a vaccine arrives.Americans will need to take pandemic precautions well into 2021 — yes, even after a vaccine arrives.

A French company with a base in Scotland has signed a deal with the UK Government to produce millions of doses of a coronavirus vaccine.A French company with a base in Scotland has signed a deal with the UK Government to produce millions of doses of a coronavirus vaccine.

Coronavirus Scotland: Valneva SE to produce Covid-19 vaccines | HeraldScotland

Page UnavailablePage Unavailable

Page Unavailable - ABC News

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...

COVID-19 Vaccine Likely Available for Public Use in November, Top Chinese Scientist Says - Sputnik International

British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Coronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 millionCoronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 million

Global report: Covid cases near 30m as China expects vaccine as soon as November | Coronavirus outbreak | The Guardian

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won’t Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

As temperatures drop, doctors expect new coronavirus cases to rise, perhaps doubling the number of US deaths by January.As temperatures drop, doctors expect new coronavirus cases to rise, perhaps doubling the number of US deaths by January.

Coronavirus pandemic expected to get worse before it gets better, experts say - CNET

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

Experts say direct delivery to the lungs may give a better immune response.Experts say direct delivery to the lungs may give a better immune response.

Coronavirus: UK to test inhaled vaccines - BBC News

The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN). The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN).

The Korea Herald

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

The studies were paused for less than a week.The studies were paused for less than a week.

AstraZeneca Resumes U.K. Clinical Trials of Its Coronavirus Vaccine After a Safety Pause | The Motley Fool

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. 

Valneva signs $1.6B supply, development agreement with U.K. for coronavirus vaccine hopeful | FiercePharma

Bloomberg - Are you a robot?

A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up. And on late Monday, the chief biosafety expert at the Chinese Centre for Disease Control told state broadcaster CCTV that a vaccine would be available to the general public "around November or December."

China says Covid-19 vaccine could be ready for public by November

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

“The complications are described in the instructions and are predictable,” Russia's health minister said.“The complications are described in the instructions and are predictable,” Russia's health minister said.

1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects - The Moscow Times

SEOUL • South Korea has said it plans to spend 172 billion won (S$198 million) to procure coronavirus vaccines, initially aiming to secure a supply for 30 million people, or 60 per cent of its population, as it battles persistent outbreaks of new cases.. Read more at straitstimes.com.East Asia News -SEOUL • South Korea has said it plans to spend 172 billion won (S$198 million) to procure coronavirus vaccines, initially aiming to secure a supply for 30 million people, or 60 per

South Korea to spend $198m to procure Covid-19 vaccines for 60% of population, East Asia News & Top Stories - The Straits Times

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released. UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released.UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released.

Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency

The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...

Coronavirus update: Global cases edge toward 30 million, and China says vaccine may be ready by November - MarketWatch

Chung said the government will negotiate with the relevant international organizations and vaccine makers to secure the early supply of the COVID-19 vaccines and would buy more as the development proceeds.Chung said the government will negotiate with the relevant international organizations and vaccine makers to secure the early supply of the COVID-19 vaccines and would buy more as the development proceeds.

S.Korea to secure coronavirus vaccines for 60 percent of population: PM Chung - World - The Jakarta Post

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Johnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday, according to the trial’s unit head Alberto Borobia.The first stage of the Phase 2 trial study of J&J’s (JNJ) vaccine, which will be conducted across three hospitals in Spain, is expected to be concludedJohnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday, according to the trial’s unit head Alberto Borobia.The first stage of the Phase 2 trial study of J&J’s (JNJ) vaccine, which will be conducted across three hospitals in Spain, is expected to be concluded

Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain – Report

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.

Coronavirus vaccine side effects: 1,000 readers asked, scientists answered